Metabolism of carbamazepine by CYP3A6: A model for in vitro drug interactions studies
Authors:
- 1 January 1999
- journal article
- Published by Elsevier in Life Sciences
- Vol. 64 (10) , 827-835
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Standard Approach to Antiepileptic Drug Treatment in the United KingdomEpilepsia, 1994
- Effect of Cigarette Smoke on Hepatic and Pulmonary Cytochromes P450 in Mouse: Evidence for CYP2E1 Induction in LungBiochemical and Biophysical Research Communications, 1994
- Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9Biochemical and Biophysical Research Communications, 1991
- Substrate specificities and functions of the P450 cytochromesLife Sciences, 1990
- Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomesBiochemical and Biophysical Research Communications, 1990
- Progabide‐Induced Changes in Carbamazepine MetabolismEpilepsia, 1988
- Interactions Between Anticonvulsants and Other Commonly Prescribed DrugsEpilepsia, 1984
- Carbamazepine Intoxication Due to Triacetyloleandomycin Administration in Epileptic PatientsEpilepsia, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976